GREATER CHINA Strategy Alpha Picks: September Conviction Calls: Add Anta, BYDE and CSCEC to our BUY list, Li Auto and OOIL to our SELL list. Take profit on Innovent, JD Logistics, Lenovo, Sino Biopharm, Tencent and TME. INDONESIA Strategy Alpha Picks: Underperformance In August: Our new Alpha Picks are ASSA, ARCI, BBCA, BBNI, BRMS, MTEL, HRUM and NCKL. MALAYSIA Strategy Alpha Picks: Wake Me Up When September Ends: Our Aug 25 Alpha Picks underperformed marginally. Sep 25 picks: Alpha IVF, Hume ...
Singapore’s 1H25 results season was resilient, with 75% of companies meeting or beating expectations despite tariff uncertainty and strength of the Singapore dollar. Banks delivered stable earnings and attractive yields, underpinning the STI. Consumer names like DFI and SSG stood out, while REITs showed positive rental reversions. Capital recycling drove upgrades for CIT and VMS. We raise our end-25 STI target to 4,602, reflecting 8% upside and attractive valuations versus history and peers.
GREATER CHINA Results CSPC Pharmaceutical Group (1093 HK/BUY/HK$10.51/Target: HK$12.00) 1H25: Results miss; expects hoh sales recovery and two more BD deals in 2H25. Ganfeng Lithium (1772 HK/BUY/HK$30.80/Target: HK$40.00) 2Q25: Net loss in line; 3Q25 turnaround on the back of lithium carbonate price recovery. Maintain BUY, target price: HK$40.00. Li Ning (2331 HK/HOLD/HK$19.70/Target: HK$18.90) 1H25: Results beat but challenges remain in 2H25; fa...
Strategy Results Roundup 1H25 results roundup: A resilient earnings season with banks carrying the load, REITs upping rents. Raising STI target to 4,602. Sector REITs Jackson Symposium provides turnaround momentum. TRADERS' CORNER Singapore Telecommunications (ST SP): Trading BUY First Resourc...
KEY HIGHLIGHTS Sector Banking: 2Q25 round-up: Delivers resilient earnings despite NIM compression. Maintain OVERWEIGHT. Results Lendlease Global Commercial REIT (LREIT SP/BUY/S$0.575/Target: S$0.79): 2HFY25: Sharpening competitive advantage by focusing on Singapore. Riverstone Holdings (RSTON SP/HOLD/S$0.69/Target: S$0.71): 2Q25: Results miss on lower ASPs; cleanroom recovery expected in 2H25. Sembcorp Industries (SCI SP/BUY/S$6.72/Target: S$7.90): 1H25: Curtail the worry – focus on defensive ...
GREATER CHINA Economics Inflation Deflationary pressures persist despite core CPI resilience. INDONESIA Update Darma Henwa (DEWA IJ/BUY/Rp222/Target: Rp372) Sustaining the growth momentum. MALAYSIA Update Uzma (UZMA MK/BUY/RM0.41/Target: RM0.76) Aggressive orderbook growth driven by O&G. However, its five-year recurring income target will miss, due to del...
SCI’s 1H25 results were resilient with net profit of S$536m in line with forecasts. Strengths include higher dividends, renewables growth, Senoko’s earnings accretion from 2H25, and a robust balance sheet with long-dated, fixed-rate debt. China renewables curtailment risk is modest, while India and new projects boost profitability. Share price weakness is overdone in our view, offering an attractive entry for patient, yield-focused investors. Maintain BUY. Target price: S$7.90.
GREATER CHINA Strategy Alpha Picks: August Conviction Calls: Add JBM Healthcare and Lenovo to our BUY list. Take profit on CATL, Han’s Laser, KE Holdings and Longfor. INDONESIA Strategy Alpha Picks: Underperformance In July: Our new Alpha Picks are ASSA, AKRA, ARCI, BBNI, KLBF, MTEL, and MYOR. MALAYSIA Strategy Alpha Picks: Some Opportunities Amid A “Summer Lull”: Our July 25 Alpha Picks outperformed. Aug 25 picks: Coraza, Eco World, Gamuda, Hume Cement, IJM, Inari, RHB and Zetrix. SINGAPORE ...
Despite the STI hitting record highs in Jul 25, our Alpha Picks portfolio managed to pull off a massive beat, increasing 17.7% mom on an equal-weighted basis and surpassing the STI by 12.4ppt. Also, on a market cap-weighted basis, our Alpha Picks portfolio grew steadily by 6.0% mom, still beating the STI by a decent 0.7ppt. For Aug 25, we add HLA, MPM and CSE while removing IFAST and SSG.
Global shipping and offshore markets have slowed in 2025 amid geopolitical uncertainty, with newbuild orders down 54% yoy and some rig dayrates showing softness. While US energy companies revealed cautious guidance at their 2Q25 earnings announcements, we remain optimistic on STM and MPM while YZJSGD’s recent rally affirms improving sentiment, with valuations remaining attractive. Sector view maintained at OVERWEIGHT.
KEY HIGHLIGHTS Sector Offshore Marine: Full steam ahead if you’re in Singapore. Top picks are Seatrium and Marco Polo Marine. Results iFAST Corp (IFAST SP/BUY/S$8.17/Target: S$9.92): 2Q25: Earnings momentum justifies higher valuation; raise target price by 36% to S$9.92. Raffles Medical Group (RFMD SP/BUY/S$1.07/Target: S$1.25): 1H25 results: A slight miss; remain hopeful for a China turnaround in 2026. TRADERS’ CORNER Singapore Post (SPOST SP): Trading SELL SIA Engineering Co (SIE SP): Tra...
GREATER CHINA Strategy Alpha Picks: July Conviction Calls: Add CATL, KE Holdings, Longfor, Midea Group, Tencent and TME to our BUY list. Take profit on Prudential. INDONESIA Strategy Alpha Picks: Good Performances In June: Our new Alpha Picks are ANTM, BBCA, ERAA, ICBP, MYOR, MIKA, AMRT and TLKM. MALAYSIA Strategy Alpha Picks: Positioning For Positive US Trade Deals: Our Jun 25 Alpha Picks outperform. Jul 25 picks: Coraza, Duopharma, Eco World, Gamuda, Hume Cement, IJM, Inari and MYEG. SINGAP...
KEY HIGHLIGHTS Update Sembcorp Industries (SCI SP/BUY/S$6.65/Target: S$8.00): Powering ahead with Singapore grids, floating solar and hydrogen dreams. Maintain BUY with target price of S$8.00. TRADERS’ CORNER Frencken Group (FRKN SP): Trading BUY Medtecs International Corp (MED SP): Trading BUY
GREATER CHINA Sector Automobile Weekly: Government steps in to restore order. Maintain MARKET WEIGHT on the sector. Top BUYs: Geely and XPeng. MALAYSIA Sector Gaming Anticipate sector earnings to progressively grow throughout 2025-26 and offer solid dividend yields, but downgrade to MARKET WEIGHT given limited immediate cataly...
SCI continues its disciplined pivot toward sustainable growth, underpinned by robust execution across renewables, energy infrastructure, and core conventional assets. The recent Senoko stake acquisition, long-term PPAs, and India renewables and battery storage projects enhance earnings visibility and regional positioning. We remain positive on SCI given its role as a scalable platform for Asia’s energy transition. Maintain BUY. Target price: S$8.00.
GREATER CHINA Strategy Alpha Picks: June Conviction Calls: Add Prudential and Sino Biopharm to our BUY list. Take profit on SHKP and Trip.com. INDONESIA Strategy Alpha Picks: Good Performances In May: Good performances from most with the exception of GOTO and BUKA. MALAYSIA Strategy Alpha Picks: Raising Emphasis On Infrastructure Plays: Our May 25 Alpha Picks outperformed with resounding success. June 25 picks: Duopharma, Eco World, Gamuda, Hume Cement, IJM, MYEG, Northeast Group. SINGAPORE S...
In Apr 25, Trump’s steep tariffs triggered a drop in oil prices amid worries about oil demand and excess OPEC supply. Shipping has also been impacted; however, this may be somewhat limited as US-China trade forms just 5% of global container volumes, offset by rapidly growing intra-Asia trade. In the drilling market, deepwater rigs are still the most resilient segment. Maintain OVERWEIGHT on the sector. Top picks are STM and MPM with YZJ appearing to have very favourable risk/reward at present.
GREATER CHINA Strategy Alpha Picks: May Conviction Calls: Add Alibaba, Innovent, Shuanghuan, Trip.com to our BUY list. Take profit on JBM Healthcare and CR Land. INDONESIA Strategy Alpha Picks: Outperformance In Apr 25: Remove ICBP, EXCL and MIKA; add BBTN and GOTO. MALAYSIA Strategy Alpha Picks: Capitalising On Sentiment Turnaround: Our Apr 25 Alpha Picks underperformed. May 25 picks: Duopharma, Gamuda, IJM, IOI Properties, TIME dotCom, MYEG, Nationgate, Northeast Group and RHB Bank. SINGAPO...
INDONESIA Strategy Alpha Picks: Outperformance In Apr 25 Remove ICBP, EXCL, and MIKA; add BBTN and GOTO. MALAYSIA Sector Property Amid tariff overhang concerns, we favour companies with clear earnings visibility, solid exposure to affordable housing, and clear re-rating catalysts. Maintain OVERWEIGHT. Update Axiata (AXIATA MK/BUY/RM2.09/Target: RM2.50) ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.